News

PERTH, West Australia, May 06, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to announce the release of its updated corporate ...
is pleased to announce the release of its updated corporate presentation, now available on the Company’s website. The new presentation outlines Novo’s strategic priorities, exploration results ...
“Our updated corporate presentation reflects the significant progress we’ve made across our exploration portfolio,” said Mr. Michael Spreadborough, Executive Co-Chairman and acting CEO of ...
PERTH, West Australia, May 06, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to announce the release of its updated corporate ...
Phong Le, Strategy CEO, introduces a groundbreaking Bitcoin-based financial model, reshaping corporate finance with real-time performance metrics and a new standard for valuation, governance, and ...
and Public Sector business, to explore practical implementation strategies that protect privacy for real-world evidence while maintaining research integrity. “This session is a must-see for ...
The videos cover roles and responsibilities, ethics and independence, people resources, and technological and intellectual resources.
Good morning. Thank you for joining the Adecco Group’s conference call today. I’m Benita Barretto, the Group’s Head of Investor Relations. Denis Machuel, the Adecco Group’s CEO; and Coram Williams, ...
Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...
Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that ...
*placebo adjusted mITT analysis; # MACE = composite of death, resuscitated cardiac arrest, acute myocardial infarction (STEMI and NSTEMI), hospitalization for unstable angina, stroke and coronary ...